List of Excipients in API nirogacestat
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nirogacestat
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | OGSIVEO | nirogacestat | 82448-050 | CELLULOSE, MICROCRYSTALLINE | 2030-11-27 |
| SpringWorks Therapeutics Inc | OGSIVEO | nirogacestat | 82448-050 | FD&C YELLOW NO. 6 | 2030-11-27 |
| SpringWorks Therapeutics Inc | OGSIVEO | nirogacestat | 82448-050 | FERRIC OXIDE YELLOW | 2030-11-27 |
| SpringWorks Therapeutics Inc | OGSIVEO | nirogacestat | 82448-050 | GLYCERYL MONOCAPRYLOCAPRATE | 2030-11-27 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for nirogacestat
Excipient focus: CELLULOSE, MICROCRYSTALLINE
nirogacestat drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
nirogacestat drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
nirogacestat drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
nirogacestat drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
nirogacestat drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nirogacestat drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
nirogacestat drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
nirogacestat drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
nirogacestat drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nirogacestat drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | nirogacestat | 82448-050 |
| >Company | >Ingredient | >NDC |
nirogacestat drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
